2024-03-28T11:43:15Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_100FC8365112
2024-03-23T01:51:08Z
serval:BIB_100FC8365112
Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type.
10.1007/BF00316110
A1990EN35400023
2095351
Meyer
J.W.
author
Woggon
B.
author
Baumann
P.
author
Meyer
U.A.
author
article
letter
1990
European journal of clinical pharmacology
0031-6970
0031-6970
journal
39
6
613-614
Adult
Debrisoquin/metabolism
Humans
Oxidation-Reduction
Polymorphism, Genetic/genetics
Schizophrenia/drug therapy
Thioridazine/blood
Thioridazine/metabolism
Thioridazine/therapeutic use
eng
60_published
peer-reviewed
Publication types: Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish